
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Hepatitis D other diagnostic studies
Introduction
Overview
Overview
The identification of the genotype of HDV helps to predict the potential severity of liver disease, as well as the response to treatment. Endoscopy may be useful in patients with advanced stage of the disease, who present with liver cirrhosis, to evaluate the presence of esophageal varices.[1][2][3]
Other Diagnostic Studies
Other Diagnostic Studies
Genotyping
The use of genotyping as a diagnostic test is gaining acceptance among different countries. The association of HDV genotype 1 with a higher degree of liver disease, and with a worst response to treatment with pegylated IFN, justifies the importance of this test.[1]
HDV genotyping is not indicated in North America and Europe as a diagnostic tool, not only because genotype 1 is the most common type in these regions, but also because the different genotypes have responded well to common antiviral treatments.[2]
Endoscopy
Patients with liver cirrhosis should be evaluated for the presence of esophageal varices.[2][3]
References
References
- β 1.0 1.1 Su CW, Huang YH, Huo TI, Shih HH, Sheen IJ, Chen SW; et al. (2006). “Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients”. Gastroenterology. 130 (6): 1625β35. doi:10.1053/j.gastro.2006.01.035. PMIDΒ 16697726.
- β 2.0 2.1 2.2 Heidrich B, Manns MP, Wedemeyer H (2013). “Treatment options for hepatitis delta virus infection”. Curr Infect Dis Rep. 15 (1): 31β8. doi:10.1007/s11908-012-0307-z. PMIDΒ 23242761.
- β 3.0 3.1 Zachou K, Yurdaydin C, Drebber U, Dalekos GN, Erhardt A, Cakaloglu Y; et al. (2010). “Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis”. Liver Int. 30 (3): 430β7. doi:10.1111/j.1478-3231.2009.02140.x. PMIDΒ 19840253.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: JoΓ£o AndrΓ© Alves Silva, M.D. [2] Jolanta Marszalek, M.D. [3]
